ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 688277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 688277; 2) Community: the network communities that were significantly associated with the response to NSC 688277; 3) Molecule: the relationships between components within communities and NSC 688277; 4) MDR: the compounds that were significantly associated with the NSC 688277.

NSC Compound Enrichment Correlation
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0135714101922724 0.43381404
NSC 701022 Null 0.0135714101922724 0.4838247
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.0135714101922724 0.21687662
NSC 751042 Null 0.0135714101922724 0.17778186
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0139796580235792 0.41378727
NSC 135880 Null 0.0139796580235792 0.3454532
NSC 303861 L-Cysteine analog 0.0139796580235792 0.50329525
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0139796580235792 0.44729584
NSC 624657 ANTINEOPLASTIC-624657 0.0139796580235792 0.22453556
NSC 633963 N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride 0.0139796580235792 0.21251789
Total:75  Current:24    [First] [Prev] [Next] [Last]